Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             130 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Achieving acceptable adiposity Purcell, Henry
2008
4 p. 159-161
artikel
2 Achieving consensus on current diabetes issues Ramsay, Scott
2010
4 p. 157-160
artikel
3 A consensus algorithm for treating hyperglycaemia in type 2 diabetes Bailey, Clifford J
2006
4 p. 147-148
artikel
4 Acute ischaemia triggers florid diabetic retinopathy in a 51-year-old woman Antonopoulou, Panagiota
2013
4 p. 215-217
artikel
5 A diabetic patient treated for hypertension develops tremors and twitches Gandhi, Nirav Y
2013
4 p. 211-214
artikel
6 An observational study of the effect of metformin on B12 status and peripheral neuropathy Chen, Shihong
2012
4 p. 189-193
artikel
7 An ‘old-fashioned’ clinical sign Wood, Daniel
2010
4 p. 205-206
artikel
8 Antiplatelet therapy and prevention of ischaemic events: CAPRIE Donnelly, Richard
2005
4 p. 203-206
artikel
9 An unusual diabetic foot collection Corfield, Lorraine
2009
4 p. 190-191
artikel
10 A patient `cured' of type 2 diabetes mellitus Ryder, Robert Ej
2004
4 p. 281-282
artikel
11 A patient's perspective Salt, Neale
2002
4 p. 330-330
artikel
12 Apomorphine SL in the treatment of erectile dysfunction Kell, Philip
2002
4 p. 296-300
artikel
13 A reversible rise in the total cholesterol to HDL ratio in a body builder Narayanan, Deepa
2012
4 p. 200-202
artikel
14 Aspects of drug development and clinical trials — Part 2 Matfin, Glenn
2007
4 p. 149-150
artikel
15 Avandamet Kunhiraman, Biju
2004
4 p. 268-271
artikel
16 Blood pressure measurement in diabetes: theory and practice Petrie, John R
2003
4 p. 258-261
artikel
17 Candy in the clinic: resistant hypertension in diabetes Teoh, Yee Ping
2003
4 p. 300-301
artikel
18 Cardiovascular benefit of intensive glucose control: approaching closure Narendran, Parth
2009
4 p. 175-176
artikel
19 Cardiovascular safety in erectile dysfunction treatment Jackson, Graham
2002
4 p. 301-304
artikel
20 Cascade screening for familial hypercholesterolaemia and its effectiveness in the prevention of vascular disease Herman, Katherine
2009
4 p. 171-174
artikel
21 Commentary: Delivering improved management and outcomes in diabetic kidney disease in routine clinical care Andrews, Peter A
2007
4 p. 179-180
artikel
22 Commentary: Documenting ethnic variations in vascular risk: where do we go from here? Sattar, Naveed
2003
4 p. 294-294
artikel
23 Commentary: Female sexual dysfunctions — the new models Steel, Judith M
2002
4 p. 271-271
artikel
24 Commentary: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? Walker, James D
2003
4 p. 282-284
artikel
25 Commentary: Treating intermittent claudication in the patients with diabetes Shearman, Cliff
2004
4 p. 243-243
artikel
26 Commonly asked questions: hypertension Petrie, John R
2003
4 p. 270-273
artikel
27 Comparing audits of cardiovascular risk in patients with diabetes in primary care Kennedy, Susan
2003
4 p. 295-299
artikel
28 Comprehensive postnatal evaluation of glucose tolerance in women with gestational diabetes Jarvis, S
2013
4 p. 218-219
artikel
29 Corrigendum 2012
4 p. 204-204
artikel
30 Curing type 2 diabetes mellitus with bariatric surgery - reality or delusion? Davies, Andrew R
2012
4 p. 173-176
artikel
31 Delivering improved management and outcomes in diabetic kidney disease in routine clinical care Hardy, Kevin J
2007
4 p. 172-182
artikel
32 Diabetes and sexual function in older adults: results of an international survey Nicolosi, Alfredo
2002
4 p. 336-339
artikel
33 Diabetes and thyroid disorders Brenta, Gabriela
2010
4 p. 172-177
artikel
34 Diabetes — from St Vincent to Glasgow. Have we progressed in 20 years? Felton, Anne-Marie
2009
4 p. 142-144
artikel
35 Diabetes medical treatment: not enough by far Wientjens, Wim H.J.M.
2009
4 p. 147-148
artikel
36 Diabetes therapies in renal impairment Bailey, Clifford J
2012
4 p. 167-171
artikel
37 Diabetic `foot-eye' syndrome Reynolds, Rebecca M
2002
4 p. 329-330
artikel
38 DIAMAP: an innovative blueprint for the future of diabetes research in Europe Halban, Philippe A.
2010
4 p. 200-202
artikel
39 Diary dates 2008
4 p. 206-206
artikel
40 Erectile dysfunction Alexander, William
2002
4 p. 244-246
artikel
41 Erectile dysfunction in patients with diabetes mellitus — advances in treatment with phosphodiesterase type 5 inhibitors Snow, Kenneth J
2002
4 p. 282-287
artikel
42 Erectile dysfunction in people from ethnic minorities Burden, Ac Felix
2002
4 p. 313-314
artikel
43 Erlotinib and gefitinib, small-molecule EGFR inhibitors. New uses for old drugs? Brooks, Marvin B
2012
4 p. 195-196
artikel
44 Focus on glycaemic management: A veritable feast or a dog's dinner? Davies, Melanie
2008
4 p. 191-194
artikel
45 Free to publish – Free to read Day, Caroline
2013
4 p. 162-163
artikel
46 From 4S to FIELD and PROactive: 10 years of CV trials in people with diabetes Mccallum, Roland W
2005
4 p. 218-225
artikel
47 Glycaemic control and cardiovascular outcome trials in type 2 diabetes Bailey, Clifford J
2012
4 p. 161-164
artikel
48 High-mix analogue insulins: do they have a therapeutic role? Grant, Paul
2009
4 p. 166-170
artikel
49 Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK Cappuccio, Francesco P
2003
4 p. 286-293
artikel
50 Hypertension in diabetes: when two worlds collide Petrie, John R
2003
4 p. 243-244
artikel
51 Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study Levy, Jonathan
2002
4 p. 278-280
artikel
52 Insulin usage in type 2 diabetes mellitus patients in UK clinical practice: a retrospective cohort-based analysis using the THIN database Evans, Marc L
2010
4 p. 178-182
artikel
53 Intermittent claudication in the patient with diabetes Jude, Edward B
2004
4 p. 238-242
artikel
54 Invasive Staphylococcus aureus infections in diabetes mellitus Hakeem, Lukman
2013
4 p. 164-177
artikel
55 Linezolid-induced hypoglycaemia in a patient with type 1 diabetes Walker, Kerry
2012
4 p. 186-188
artikel
56 Lipid-lowering therapy is associated with resolution of exudates in diabetic maculopathy Sheth, Hiten G
2006
4 p. 181-183
artikel
57 Looking at the Russian health care system: through the eyes of patients with diabetes and their physicians Kühlbrandt, Charlotte
2012
4 p. 181-184
artikel
58 Low-dose statins: useful and safe? Schachter, Mike
2004
4 p. 260-262
artikel
59 Management of the obese child — Application of NICE guidelines 2006 Matyka, Krystyna A
2008
4 p. 178-182
artikel
60 Manifestation of lower extremity atherosclerosis in patients with high ankle-brachial index Hong Zhang,
2009
4 p. 160-164
artikel
61 Metformin effects on treatment satisfaction and quality of life in gestational diabetes Latif, Lamis
2013
4 p. 178-182
artikel
62 Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation Mamputu, Jean-Claude
2003
4 p. 302-310
artikel
63 Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis Nwaneri, Chukwuemeka
2013
4 p. 192-207
artikel
64 New Perspectives on the Management of Type 2 Diabetes Barnett, Anthony
2008
4 p. 198-205
artikel
65 New prolonged-release metformin improves gastrointestinal tolerability Davidson, Jaime
2004
4 p. 273-277
artikel
66 NICE and hypertension — the judge's decision is final! Kirby, Michael G
2006
4 p. 177-179
artikel
67 NICE guidelines and diabetic retinopathy Scarpello, John
2002
4 p. 311-312
artikel
68 NICE guidelines: renal disease — prevention and early management Andrews, Peter
2002
4 p. 309-310
artikel
69 Non-invasive imaging for coronary artery disease in diabetes Tschoepe, Diethelm
2004
4 p. 245-250
artikel
70 Not all hyperglycaemia is the same: an interesting case of secondary diabetes Baker, Kerri
2010
4 p. 207-208
artikel
71 Obesity treatment: the key to managing the type 2 diabetes timebomb? Wilding, John
2004
4 p. 217-219
artikel
72 Odontoid peg and skull base osteomyelitis presenting as Streptococcus pneumoniae meningitis in diabetes mellitus Hakeem, Lukman
2013
4 p. 208-210
artikel
73 Optimising treatment of hypertension to prevent cardiovascular complications in type 2 diabetes Daly, Caroline
2003
4 p. 274-276
artikel
74 Overcoming the barriers to effective glycaemic control for type 2 diabetes Reasner, Charles A
2002
4 p. 290-295
artikel
75 Paradoxical fall in HDL cholesterol observed in a patient treated with rosiglitazone and pioglitazone Saraf, Sanjay
2009
4 p. 186-189
artikel
76 Pathophysiology of erectile dysfunction Eardley, Ian
2002
4 p. 272-276
artikel
77 Pica in pregnant women with diabetes: Does it really exist? Okunoye, Gbemisola O
2013
4 p. 183-186
artikel
78 Pioglitazone — an oral antidiabetic agent and metabolic syndrome modulator. Can theory translate into practice? Campbell, Ian W
2005
4 p. 209-216
artikel
79 PPAR γ Agonists and the Future for Insulin Sensitizers: A report of a debate and presentations on the subject at the 72nd Scientific Sessions of the American Diabetes Association, Philadelphia, 8-12 June, 2012 Henry, Robert R
2012
4 p. 206-210
artikel
80 Prevalence of diabetes in patients admitted to a cancer hospital Morganstein, DL
2012
4 p. 178-180
artikel
81 Quantifying changes in retinal anatomy after interventions for diabetic maculopathy Soomro, Hibba
2007
4 p. 181-185
artikel
82 Recurrent cranial neuropathy in diabetes Swaminathan, Krishnan
2012
4 p. 198-199
artikel
83 Reply: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? Sawicki, Peter T
2003
4 p. 285-285
artikel
84 Resistant hypertension as a pointer to unsuspected Cushing’s syndrome in patients with diabetes: three case reports Hewapathirana, Niranjala
2010
4 p. 183-186
artikel
85 Results of the LEAD-2 study in relation to NICE and ADA/EASD guidelines for the treatment of type 2 diabetes in the UK Wilding, John
2009
4 p. 177-185
artikel
86 Review: Adiponectin for prediction of cardiovascular risk? Karastergiou, Kalypso
2009
4 p. 150-154
artikel
87 Review: Challenges in developing therapies for the metabolic syndrome Matfin, Glenn
2007
4 p. 152-156
artikel
88 Review: Diabetes and assisted reproductive technology Taylor, Clare T
2002
4 p. 247-253
artikel
89 Review: Female sexual dysfunctions — the new models Basson, Rosemary
2002
4 p. 267-270
artikel
90 Review: Hypertension in diabetes: a perspective from clinical pharmacology Ross, Sarah
2003
4 p. 252-256
artikel
91 Review: Imaging to assess effect of medical therapy in patients with diabetes mellitus Raggi, Paolo
2007
4 p. 157-164
artikel
92 Review: Implications from hypertension outcome trials for the management of patients with hypertension and diabetes Brown, Morris J
2003
4 p. 245-251
artikel
93 Review: Inhibition of dipeptidyl peptidase-4 with vildagliptin: a potential new treatment for type 2 diabetes Pratley, Richard E
2006
4 p. 150-156
artikel
94 Review: Insulin secretion: function and therapy of pancreatic beta-cells in diabetes Rorsman, Patrik
2005
4 p. 187-191
artikel
95 Review: Mechanisms contributing to the development of type 2 diabetes Jayapaul, Muthu K
2004
4 p. 227-231
artikel
96 Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development Greenstein, Adam
2007
4 p. 166-171
artikel
97 Review: Modern treatment of erectile dysfunction Ali, Waleed
2002
4 p. 255-261
artikel
98 Review: Sulphonylureas and cardiovascular risk: facts and controversies Valensi, Paul
2006
4 p. 159-165
artikel
99 Review: Sulphonylureas and the rise and fall of beta-cell function Matthews, David R
2005
4 p. 192-196
artikel
100 Review: The importance of effective early phase insulin secretion Del Prato, Stefano
2005
4 p. 198-202
artikel
101 Review: The varied attractions of the diabetic foot Leese, Graham P
2009
4 p. 155-159
artikel
102 Review: The vascular system and erectile dysfunction in diabetes — the role of penile Doppler Jones, Robert WA
2002
4 p. 263-265
artikel
103 Review: When should bariatric surgery be used in the treatment of type 2 diabetes? Pinkney, Jonathan
2004
4 p. 232-237
artikel
104 Schedule 11 — impact on treating erectile dysfunction Hackett, Geoff
2002
4 p. 315-318
artikel
105 Screening for IGT and diabetes Tringham, Jennifer R
2004
4 p. 254-258
artikel
106 Screening for type 2 diabetes mellitus in children and adolescents Agwu, J Chizo
2008
4 p. 163-168
artikel
107 SGLT2 inhibitors: glucuretic treatment for type 2 diabetes Bailey, Clifford J
2010
4 p. 193-199
artikel
108 Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? A systematic review of randomised controlled trials Kaiser, Thomas
2003
4 p. 278-281
artikel
109 Sildenafil citrate in the management of diabetic erectile dysfunction Hackett, Geoff
2002
4 p. 306-308
artikel
110 Sildenafil in diabetic peripheral neuropathy Sairam, Krishnamurthy
2002
4 p. 304-304
artikel
111 Sildenafil in diabetic peripheral neuropathy Sairam, Krishnamurthy
2002
4 p. 304-304
artikel
112 `Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) Mcinnes, Gordon T
2003
4 p. 263-267
artikel
113 Switching basal analogue insulins — short-term weight effects Ubogagu, Edith
2008
4 p. 183-186
artikel
114 Team skills Johnson, David
2002
4 p. 327-328
artikel
115 The Alphabet Strategy and standards of care in young adults with type 1 diabetes Gholap, Nitin
2006
4 p. 168-170
artikel
116 The association of periodontal disease, diabetes and cardiovascular disease Gadsby, Roger
2008
4 p. 188-189
artikel
117 The Diabetes Care Technician Roland, Jonathan
2004
4 p. 278-280
artikel
118 The Diabetes Prevention Program: will it really change the way we manage glycaemia? Slama, Gérard
2002
4 p. 319-322
artikel
119 The importance of assessing and treating sexual dysfunction in the cardiac patient Martin, Emma
2002
4 p. 324-326
artikel
120 The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes Schnabel, Catherine A
2005
4 p. 227-235
artikel
121 The MERCURY II trial: benefits of rosuvastatin Izzat, Lena
2006
4 p. 171-176
artikel
122 The new world of biosimilars: what diabetologists need to know about biosimilar insulins Krämer, Irene
2010
4 p. 163-171
artikel
123 The tolerability and safety of DPP-4 inhibitors for the treatment of older people with type 2 diabetes mellitus: an observational study Viljoen, Adie
2013
4 p. 187-191
artikel
124 Tight glycaemic control: the key to improving the management of type 2 diabetes Alberti, George
2005
4 p. 184-185
artikel
125 TRAQ-D (Trinidad Risk Assessment Questionnaire for Type 2 Diabetes Mellitus): a cheap, reliable, non-invasive screening tool for diabetes Latchan, Zaafir
2010
4 p. 187-192
artikel
126 Unusual cause of leg pain: Diabetic pyomyositis Mclaughlan, Lorraine
2008
4 p. 196-196
artikel
127 Use of U-500 insulin in continuous subcutaneous insulin infusion in a patient with severe insulin resistance Sennik, Devesh
2010
4 p. 203-204
artikel
128 Weight gain and insulin therapy Khan, Rehman
2004
4 p. 264-267
artikel
129 Weight management and cardiovascular disease: implications of recent and ongoing clinical trials Wilding, John
2008
4 p. 170-176
artikel
130 Wolfram syndrome: DIDMOAD Wake, Deborah J
2005
4 p. 236-237
artikel
                             130 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland